BrightSpring Health Services Inc has a consensus price target of $19.42 based on the ratings of 14 analysts. The high is $30 issued by UBS on January 29, 2025. The low is $11.5 issued by Deutsche Bank on February 20, 2024. The 3 most-recent analyst ratings were released by UBS, Morgan Stanley, and CJS Securities on January 29, 2025, December 17, 2024, and December 12, 2024, respectively. With an average price target of $25.67 between UBS, Morgan Stanley, and CJS Securities, there's an implied 31.62% upside for BrightSpring Health Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by UBS on January 29, 2025. The analyst firm set a price target for $30.00 expecting BTSG to rise to within 12 months (a possible 53.85% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by UBS, and BrightSpring Health maintained their buy rating.
There is no last upgrade for BrightSpring Health
There is no last downgrade for BrightSpring Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on January 29, 2025 so you should expect the next rating to be made available sometime around January 29, 2026.
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $22.00 to $30.00. The current price BrightSpring Health (BTSG) is trading at is $19.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.